Tag Archives: Critical Path to TB Drug Regimens

Good Participatory Practice TB drug trial guidelines lay groundwork for research, use of new treatments

By on .

If you consider all the years that time stood still in the world of tuberculosis drug research, the most compelling aspect of the Good Participatory Practice Guidelines for TB Drug Trials just released by a Critical Paths to TB Drug Regimens working group is that occasions exist for them to be used. With nearly half […]

Public and Private Sector Partners Help to Jump Start Development of New TB Drug Combinations

By on .

This post is by Global Center Director Christine Lubinski. The excitement in the room was palatable today as FDA Commissioner Margaret Hamburg joined representatives from the Global Alliance for TB Drug Development, the Bill & Melinda Gates Foundation, the Treatment Action Campaign, and representatives from the pharmaceutical industry to announce a new collaboration to accelerate […]